{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:18:39Z","timestamp":1790713119020,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":1310,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1124\/jpet.121.000525","type":"journal-article","created":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T15:35:14Z","timestamp":1615476914000},"page":"326-335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Therapeutic Assessment of Combination Therapy with a Neprilysin Inhibitor and Angiotensin Type 1 Receptor Antagonist on Angiotensin II\u2013Induced Atherosclerosis, Abdominal Aortic Aneurysms, and Hypertension"],"prefix":"10.1016","volume":"377","author":[{"given":"Yasir","family":"Alsiraj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean E.","family":"Thatcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching Ling","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Ensor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Cassis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.121.000525_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/01.HYP.20.1.89","article-title":"Role of neutral endopeptidase in the metabolism of endothelin","volume":"20","author":"Abassi","year":"1992","journal-title":"Hypertension"},{"key":"10.1124\/jpet.121.000525_bib2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/1358863X17745150","article-title":"B-type natriuretic peptide for prediction of incident clinically significant abdominal aortic aneurysm: a population-based prospective study","volume":"23","author":"Acosta","year":"2018","journal-title":"Vasc Med"},{"key":"10.1124\/jpet.121.000525_bib3","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1038\/s41467-019-10462-z","article-title":"XX sex chromosome complement promotes atherosclerosis in mice","volume":"10","author":"Alsiraj","year":"2019","journal-title":"Nat Commun"},{"key":"10.1124\/jpet.121.000525_bib4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1161\/ATVBAHA.117.310035","article-title":"Sex chromosome complement defines diffuse versus focal angiotensin II-induced aortic pathology","volume":"38","author":"Alsiraj","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/jpet.121.000525_bib5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1161\/CIRCULATIONAHA.116.023789","article-title":"Female mice with an XY sex chromosome complement develop severe angiotensin II-induced abdominal aortic aneurysms","volume":"135","author":"Alsiraj","year":"2017","journal-title":"Circulation"},{"key":"10.1124\/jpet.121.000525_bib6","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0021-9150(00)00565-7","article-title":"Omapatrilat, a dual angiotensin-converting enzyme and neutral endopeptidase inhibitor, prevents fatty streak deposit in apolipoprotein E-deficient mice","volume":"155","author":"Arnal","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1124\/jpet.121.000525_bib7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ejphar.2015.05.059","article-title":"Pre-treatment with LCZ696, an orally active angiotensin receptor neprilysin inhibitor, prevents ischemic brain damage","volume":"762","author":"Bai","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.121.000525_bib8","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jacc.2016.04.060","article-title":"A test in context: neprilysin: function, inhibition, and biomarker","volume":"68","author":"Bayes-Genis","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/jpet.121.000525_bib9","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/0735-1097(94)90385-9","article-title":"Relation of neurohumoral activation to clinical variables and degree of ventricular dysfunction: a report from the Registry of Studies of Left Ventricular Dysfunction","volume":"23","author":"Benedict","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/jpet.121.000525_bib10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jvs.2012.07.053","article-title":"B-type natriuretic peptide predicts postoperative cardiac events and mortality after elective open abdominal aortic aneurysm repair","volume":"57","author":"Bryce","year":"2013","journal-title":"J Vasc Surg"},{"key":"10.1124\/jpet.121.000525_bib11","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.jvs.2019.02.041","article-title":"Preoperative biomarker evaluation for the prediction of cardiovascular events after major vascular surgery","volume":"70","author":"Chan","year":"2019","journal-title":"J Vasc Surg"},{"key":"10.1124\/jpet.121.000525_bib12","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.jacbts.2020.07.006","article-title":"Differential effects of sacubitril\/valsartan on diastolic function in mice with obesity-related metabolic heart disease","volume":"5","author":"Croteau","year":"2020","journal-title":"JACC Basic Transl Sci"},{"key":"10.1124\/jpet.121.000525_bib13","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1749-6632.1999.tb07789.x","article-title":"Chronic angiotensin II infusion promotes atherogenesis in low density lipoprotein receptor -\/- mice","volume":"892","author":"Daugherty","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"10.1124\/jpet.121.000525_bib14","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1172\/JCI7818","article-title":"Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice","volume":"105","author":"Daugherty","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.121.000525_bib15","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/sj.bjp.0704331","article-title":"Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis","volume":"134","author":"Daugherty","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.121.000525_bib16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1096\/fasebj.3.2.2521610","article-title":"Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones","volume":"3","author":"Erd\u00f6s","year":"1989","journal-title":"FASEB J"},{"key":"10.1124\/jpet.121.000525_bib17","first-page":"S24","article-title":"Renal metabolism of angiotensin I and II","volume":"30","author":"Erd\u00f6s","year":"1990","journal-title":"Kidney Int Suppl"},{"key":"10.1124\/jpet.121.000525_bib18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.amjcard.2006.01.058","article-title":"Association of plasma N-terminal pro-B-type natriuretic peptide with postoperative cardiac events in patients undergoing surgery for abdominal aortic aneurysm or leg bypass","volume":"98","author":"Feringa","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1124\/jpet.121.000525_bib19","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/hrt.2006.093716","article-title":"Plasma N-terminal pro-B-type natriuretic peptide as long-term prognostic marker after major vascular surgery","volume":"93","author":"Feringa","year":"2007","journal-title":"Heart"},{"key":"10.1124\/jpet.121.000525_bib20","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1161\/01.CIR.97.23.2323","article-title":"Inhibition of neutral endopeptidase causes vasoconstriction of human resistance vessels in vivo","volume":"97","author":"Ferro","year":"1998","journal-title":"Circulation"},{"key":"10.1124\/jpet.121.000525_bib21","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1161\/CIRCULATIONAHA.115.016537","article-title":"Circulating biomarkers and abdominal aortic aneurysm incidence: the Atherosclerosis Risk in Communities (ARIC) study","volume":"132","author":"Folsom","year":"2015","journal-title":"Circulation"},{"key":"10.1124\/jpet.121.000525_bib22","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1161\/01.CIR.101.16.1976","article-title":"Modulation of functionally active endothelin-converting enzyme by chronic neutral endopeptidase inhibition in experimental atherosclerosis","volume":"101","author":"Grantham","year":"2000","journal-title":"Circulation"},{"key":"10.1124\/jpet.121.000525_bib23","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/0091270009343932","article-title":"Pharmacokinetics and pharmacodynamics of LCZ696, a novel dual-acting angiotensin receptor-neprilysin inhibitor (ARNi)","volume":"50","author":"Gu","year":"2010","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/jpet.121.000525_bib24","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1210\/en.2003-1615","article-title":"Orchidectomy, but not ovariectomy, regulates angiotensin II-induced vascular diseases in apolipoprotein E-deficient mice","volume":"145","author":"Henriques","year":"2004","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.121.000525_bib25","doi-asserted-by":"crossref","first-page":"e49642","DOI":"10.1371\/journal.pone.0049642","article-title":"Efficacy and mechanism of angiotensin II receptor blocker treatment in experimental abdominal aortic aneurysms","volume":"7","author":"Iida","year":"2012","journal-title":"PLoS One"},{"key":"10.1124\/jpet.121.000525_bib26","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jacbts.2017.08.001","article-title":"Cardioprotective effects of LCZ696 (sacubitril\/valsartan) after experimental Acute myocardial infarction","volume":"2","author":"Ishii","year":"2017","journal-title":"JACC Basic Transl Sci"},{"key":"10.1124\/jpet.121.000525_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jama.2019.12821","article-title":"Association of change in N-terminal pro-B-type natriuretic peptide following initiation of sacubitril-valsartan treatment with cardiac structure and function in patients with heart failure with reduced ejection fraction","volume":"322","author":"Januzzi","year":"2019","journal-title":"JAMA"},{"key":"10.1124\/jpet.121.000525_bib28","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1016\/S0735-1097(01)01672-2","article-title":"Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure","volume":"38","author":"Koglin","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/jpet.121.000525_bib29","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1111\/bph.14708","article-title":"Strain-selective efficacy of sacubitril\/valsartan on carotid fibrosis in response to injury in two inbred mouse strains","volume":"176","author":"Korshunov","year":"2019","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.121.000525_bib30","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1161\/01.ATV.16.8.1080","article-title":"Suppression of atherosclerotic changes in cholesterol-fed rabbits treated with an oral inhibitor of neutral endopeptidase 24.11 (EC 3.4.24.11)","volume":"16","author":"Kugiyama","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/jpet.121.000525_bib31","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1254\/jphs.12031FP","article-title":"Add-on aliskiren elicits stronger renoprotection than high-dose valsartan in type 2 diabetic KKAy mice that do not respond to low-dose valsartan","volume":"119","author":"Lei","year":"2012","journal-title":"J Pharmacol Sci"},{"key":"10.1124\/jpet.121.000525_bib32","first-page":"59","article-title":"Omapatrilat, an angiotensin-converting enzyme and neutral endopeptidase inhibitor, attenuates early atherosclerosis in diabetic and in nondiabetic low-density lipoprotein receptor-deficient mice","volume":"4","author":"Levy","year":"2003","journal-title":"Int J Exp Diabesity Res"},{"key":"10.1124\/jpet.121.000525_bib33","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s10557-020-06995-x","article-title":"Protection of sacubitril\/valsartan against pathological cardiac remodeling by inhibiting the NLRP3 inflammasome after relief of pressure overload in mice","volume":"34","author":"Li","year":"2020","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1124\/jpet.121.000525_bib34","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1177\/1060028015593093","article-title":"Dual angiotensin receptor and neprilysin inhibition with sacubitril\/valsartan in chronic systolic heart failure: understanding the New PARADIGM","volume":"49","author":"Lillyblad","year":"2015","journal-title":"Ann Pharmacother"},{"key":"10.1124\/jpet.121.000525_bib35","first-page":"1099","article-title":"Hypercholesterolemia accelerates both the initiation and progression of angiotensin II-induced abdominal aortic aneurysms","volume":"6","author":"Liu","year":"2020","journal-title":"Ann Vasc Med Res"},{"key":"10.1124\/jpet.121.000525_bib36","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1161\/ATVBAHA.116.307613","article-title":"Hypercholesterolemia induced by a PCSK9 gain-of-function mutation augments angiotensin II-induced abdominal aortic aneurysms in C57bl\/6 mice-brief report","volume":"36","author":"Lu","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/jpet.121.000525_bib37","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/CIRCULATIONAHA.114.013748","article-title":"Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure","volume":"131","author":"Packer","year":"2015","journal-title":"Circulation"},{"key":"10.1124\/jpet.121.000525_bib38","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/sj.bjp.0705219","article-title":"Effects of the neutral endopeptidase inhibitor thiorphan on cardiovascular and renal function in cirrhotic rats","volume":"139","author":"Park","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.121.000525_bib39","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.jvs.2008.05.015","article-title":"N-terminal pro B-type natriuretic peptide is an independent predictor of postoperative myocardial injury in patients undergoing major vascular surgery","volume":"48","author":"Rajagopalan","year":"2008","journal-title":"J Vasc Surg"},{"key":"10.1124\/jpet.121.000525_bib40","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1042\/CS20160197","article-title":"Blood pressure-independent renoprotection in diabetic rats treated with AT1 receptor-neprilysin inhibition compared with AT1 receptor blockade alone","volume":"130","author":"Roksnoer","year":"2016","journal-title":"Clin Sci (Lond)"},{"key":"10.1124\/jpet.121.000525_bib41","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/ki.2015.107","article-title":"Optimum AT1 receptor-neprilysin inhibition has superior cardioprotective effects compared with AT1 receptor blockade alone in hypertensive rats","volume":"88","author":"Roksnoer","year":"2015","journal-title":"Kidney Int"},{"key":"10.1124\/jpet.121.000525_bib42","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S0735-1097(99)00593-8","article-title":"Vascular actions of brain natriuretic peptide: modulation by atherosclerosis and neutral endopeptidase inhibition","volume":"35","author":"Schirger","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/jpet.121.000525_bib43","doi-asserted-by":"crossref","first-page":"48066","DOI":"10.1074\/jbc.M204058200","article-title":"Human adipose tissue cells keep tight control on the angiotensin II levels in their vicinity","volume":"277","author":"Schling","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.121.000525_bib44","first-page":"310","article-title":"Renin release","volume":"22","author":"Schweda","year":"2007","journal-title":"Physiology (Bethesda)"},{"key":"10.1124\/jpet.121.000525_bib45","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.jvs.2018.11.045","article-title":"Mas receptor deficiency augments angiotensin II-induced atherosclerosis and aortic aneurysm ruptures in hypercholesterolemic male mice","volume":"70","author":"Stegbauer","year":"2019","journal-title":"J Vasc Surg"},{"key":"10.1124\/jpet.121.000525_bib46","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.cardfail.2020.04.011","article-title":"Sacubitril\/valsartan improves left ventricular function in chronic pressure overload independent of intact cyclic guanosine monophosphate-dependent protein kinase I alpha signaling","volume":"26","author":"Tam","year":"2020","journal-title":"J Card Fail"},{"key":"10.1124\/jpet.121.000525_bib47","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1161\/ATVBAHA.114.304613","article-title":"Angiotensin-converting enzyme 2 decreases formation and severity of angiotensin II-induced abdominal aortic aneurysms","volume":"34","author":"Thatcher","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/jpet.121.000525_bib48","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1053\/j.jvca.2012.01.018","article-title":"Prognostic power of pre- and postoperative B-type natriuretic peptide levels in patients undergoing abdominal aortic surgery","volume":"26","author":"Vetrugno","year":"2012","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1124\/jpet.121.000525_bib49","doi-asserted-by":"crossref","first-page":"14150","DOI":"10.1016\/S0021-9258(18)77280-3","article-title":"The hydrolysis of endothelins by neutral endopeptidase 24.11 (enkephalinase)","volume":"265","author":"Vijayaraghavan","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.121.000525_bib50","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3317\/jraas.2003.031","article-title":"Effect of chronic treatment with the vasopeptidase inhibitor AVE 7688 and ramipril on endothelial function in atherogenic diet rabbits [published correction appears in J Renin Angiotensin Aldosterone Syst (2004) 5:58]","volume":"4","author":"Weckler","year":"2003","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1124\/jpet.121.000525_bib51","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1161\/hc4601.099404","article-title":"Roles of angiotensin II type 2 receptor stimulation associated with selective angiotensin II type 1 receptor blockade with valsartan in the improvement of inflammation-induced vascular injury","volume":"104","author":"Wu","year":"2001","journal-title":"Circulation"},{"key":"10.1124\/jpet.121.000525_bib52","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1161\/HYPERTENSIONAHA.109.133884","article-title":"Aliskiren enhances the protective effects of valsartan against cardiovascular and renal injury in endothelial nitric oxide synthase-deficient mice","volume":"54","author":"Yamamoto","year":"2009","journal-title":"Hypertension"},{"key":"10.1124\/jpet.121.000525_bib53","doi-asserted-by":"crossref","first-page":"R244","DOI":"10.1152\/ajpregu.00323.2011","article-title":"Adipocyte-specific deficiency of angiotensinogen decreases plasma angiotensinogen concentration and systolic blood pressure in mice","volume":"302","author":"Yiannikouris","year":"2012","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1124\/jpet.121.000525_bib54","doi-asserted-by":"crossref","first-page":"6509","DOI":"10.1038\/s41598-019-42994-1","article-title":"Neprilysin inhibitor-angiotensin II receptor blocker combination therapy (Sacubitril\/valsartan) suppresses atherosclerotic plaque formation and inhibits inflammation in apolipoprotein E- deficient mice","volume":"9","author":"Zhang","year":"2019","journal-title":"Sci Rep"}],"updated-by":[{"DOI":"10.1124\/jpet.121.000525err","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000}}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524276771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524276771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.121.000525","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T14:03:52Z","timestamp":1739973832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524276771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0022356524276771"],"URL":"https:\/\/doi.org\/10.1124\/jpet.121.000525","relation":{"erratum":[{"id-type":"doi","id":"10.1124\/jpet.121.000525err","asserted-by":"object"}]},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic Assessment of Combination Therapy with a Neprilysin Inhibitor and Angiotensin Type 1 Receptor Antagonist on Angiotensin II\u2013Induced Atherosclerosis, Abdominal Aortic Aneurysms, and Hypertension","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.121.000525","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s).","name":"copyright","label":"Copyright"}]}}